Top Markets
Coin of the day
Maxigen Biotech Inc. Maxigen Biotech Inc.

Maxigen Biotech Inc.

1783
Classificação em ações #21087
Maxigen Biotech Inc. (MBI) is a company dedicated to the research, development,... Maxigen Biotech Inc. (MBI) is a company dedicated to the research, development, production, and global commercialization of advanced biomedical and skincare solutions. Its extensive biomedical portfolio includes various orthopedic products such as Formagraft, a bone graft substitute, and Formasetin, a bone void filler. For intra-articular applications in orthopedics, MBI markets injections under the names ArtiAid, ArtiAid Plus, and ArtiBest. The company's offerings also span both orthopedic and dental fields, featuring Foramic, a bone substitute granule; MaxiBone, a calcium phosphate ceramic; and GingivAid, a collagen dental graft. Specifically for dental use, MBI provides FormaAid, a collagen membrane, and the E-TECH DENTISTAR II sterilizer and disinfectant. Furthermore, HealiAid, a collagen wound dressing product, serves dental and general wound care purposes. MBI also manufactures ophthalmic viscoelastic devices, known as ViscAid, PreviscAid, and BiVisc, and produces Formaderm, a dermal filler injection utilized in plastic surgery. Beyond its medical devices, Maxigen Biotech Inc. offers a comprehensive line of skincare products. This array includes masks for the face, neck, body, and limbs, alongside make-up removers, cleansers, exfoliants, toners, essences, men's grooming items, sunscreens, and specialized body, hand, and foot care formulations. Maxigen Biotech Inc. was established in 1998 and operates from its main office in Taoyuan City, Taiwan.
Preço da ação
$1.28
Última sincronização: 2026-08-21
Valor de mercado
$115.23M
Variação (1 dia)
-0.25%
Variação (1 ano)
-10.17%
País
TW
Negociar Maxigen Biotech Inc. (1783)

Categoria

Preço 1783 com a capitalização de mercado de B
Maxigen Biotech Inc. Maxigen Biotech Inc.
1783
$1.28
Capitalização de mercado de Maxigen Biotech Inc.(1783)
Valor de mercado: $115.23M
Em August 2026, Maxigen Biotech Inc. tem uma capitalização de mercado de $115.23M. Isso faz com que Maxigen Biotech Inc. seja a 21087th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Maxigen Biotech Inc. de 2012 a 2026
1783 comparado com o topo de 5 mais populares stocks
Preço para 1783 Ativo B Capitalização de mercado de B Resultados
Maxigen Biotech Inc. Maxigen Biotech Inc.
$58,099.29 $115.23M
$5.211T +4,522,369.46%
Maxigen Biotech Inc. Maxigen Biotech Inc.
$50,689.70 $115.23M
$4.547T +3,945,604.16%
Maxigen Biotech Inc. Maxigen Biotech Inc.
$46,405.64 $115.23M
$4.162T +3,612,131.42%
Maxigen Biotech Inc. Maxigen Biotech Inc.
$40,054.47 $115.23M
$3.593T +3,117,753.81%
Maxigen Biotech Inc. Maxigen Biotech Inc.
$31,136.32 $115.23M
$2.793T +2,423,562.31%